Open Access

REVIEW

Use of Impella cardiac axial flow pump for cardiogenic shock (A newer alternative)–How good is the evidence?

RAFIQ AHMED BHAT¹, SYED MANZOOR ALI², YOOSUF ALI ASHRAF MUHAMMAD HUSSENBOCUS³, AKANKSHA RATHI⁴, JAVAID AKHTER BHAT⁵, ABDUL ALEEM KHAN⁶, SYED MAQBOOL², RAJA SAQIB IQBAL⁷, MD MONOWARUL ISLAM⁸, YONGSHENG QU⁹, YOU ZHANG⁹, YUXIAO SUN¹, WENTAO XIAO⁹, ABHISHEK TIBREWAL¹⁰, CHUANYU GAO^1,*

1 Zhengzhou University People’s Hospital, Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Zhengzhou, China
2 Department of Cardiology, Super Speciality Division, Government Medical College, Srinagar, India
3 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China
4 Department of Community Medicine, Vedanta Institute of Medical Sciences, Palghar, India
5 State Key Laboratory of Crop Genetics and Germplasm Enhancement, Nanjing Agricultural University, Nanjing, China
6 Department of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
7 Department of Paediatrics, Batra Hospital and Medical Research Centre, New Delhi, India
8 Zhengzhou University First Affiliated Hospital, Zhengzhou, China
9 Zhengzhou University People’s Hospital, Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Zhengzhou, China
10 Department of Community Medicine, Institute of Biostatistics and Epidemiology, Gurgaon, India

* Address correspondence to: Chuanyu Gao,